| Early Temozolomide in Patients With High-Grade Gliomas in Rehabilitation (NCT03796507) | University of Rochester | 2021-09-01 |
| Precise DCE-MRI in Diagnosing Participants With Recurrent High Grade Glioma or Melanoma Brain Metastases (NCT03698162) | University of Southern California | 2021-04-13 |
| A Large-scale Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96 (NCT03650257) | Cure&Sure Biotech Co., LTD | 2019-08-21 |
| Efficacy of Kangliuwan for Recurrent Grade IV Glioma (NCT03949192) | Xuanwu Hospital, Beijing | 2019-06-28 |
| Intratumorally-Administered Topotecan Using Convection-Enhanced Delivery in Patients With Grade III/ IV Glioma (NCT03927274) | H. Lee Moffitt Cancer Center and Research Institute | 2019-06-20 |
| Safety and Efficacy of L19TNF in Patients With Isocitrate Dehydrogenase (IDH) Wildtype WHO Grade III / IV Glioma at First Relapse (NCT03779230) | Philogen S.p.A. | 2019-05-31 |
| A Study Utilizing Escitalopram in Glioma Patients (NCT03728673) | University of Nebraska | 2019-03-06 |
| Pilot Study of Mirtazapine for the Dual Tx of Depression and CINV in High-Grade Glioma Pts on TMZ (NCT03935685) | University of California, Irvine | 2019-02-26 |
| Seizure Prophylaxis in Patients With Glioma or Brain Metastasis (NCT03436433) | Duke University | 2019-01-31 |
| A Phase 0/I Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Recurrent High-Grade Glioma Patients Scheduled for Resection (NCT03834740) | St. Joseph's Hospital and Medical Center, Phoenix | 2019-01-19 |
| Visual Study of Molecular Genotype in Glioma Evolution (NCT03750890) | Tongji Hospital | 2019-01-01 |
| Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma (NCT03739372) | University of California, San Francisco | 2018-11-28 |
| Pembrolizumab in Association With the IMA950/Poly-ICLC for Relapsing Glioblastoma (NCT03665545) | University Hospital, Geneva | 2018-10-25 |
| Evaluation of Functional Magnetic Resonance Imaging (fMRI) in Patients Who Speak Two Languages Fluently (NCT03496181) | Memorial Sloan Kettering Cancer Center | 2018-03-30 |
| Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors (NCT03194906) | St. Jude Children's Research Hospital | 2017-11-07 |
| Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM (NCT03213002) | Northwell Health | 2017-06-13 |
| The Efficacy of APT Magnetic Resonance Imaging in Predicting the Efficacy of Bevacizumab in Recurrent Malignant Gliomas (NCT03180697) | Zhujiang Hospital | 2017-06-03 |
| Noninvasively Predicting Gene Status of Glioma (NCT03102112) | Tang-Du Hospital | 2017-01-01 |
| Glioma Microenvironment an Exploratory Study (NCT03189420) | Hospital Sirio-Libanes | 2016-10-01 |
| Neuropsychological and Oncological Outcomes in Grade 2 or 3 Glioma Patients Undergoing Postoperative Modern Radiotherapy (NCT03534050) | Chang Gung Memorial Hospital | 2016-08-01 |
| Longitudinal Analysis of the Health-related Quality of Life in Glioma Patients (NCT03849430) | Universitaire Ziekenhuizen KU Leuven | 2015-12-14 |
| CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients (NCT04406610) | Fuda Cancer Hospital, Guangzhou | 2015-09-01 |
| Blood Biomarker Signature in Glioma (NCT03698201) | Cancer Trials Ireland | 2009-07-01 |
| Expanded Access for Pembrolizumab (MK-3475) (NCT03311542) | Center Trials & Treatment | |
| An Expanded Access Program of Ipilimumab for Patients With Glioblastomas and Gliomas (NCT03460782) | Center Trials & Treatment | |